University of Maryland Medical Center | oneAMYLOIDOSISvoice
Academic & Health Care Centers

University of Maryland Medical Center

22 South Greene St.
Baltimore, Maryland, United States
Phone   Web  
University of Maryland Medical Center is the Medical System’s flagship academic medical center. The hospital provides comprehensive care for the West Baltimore community and tertiary care for Maryland and the surrounding areas. 
At the University of Maryland Heart and Vascular Center, cardiac amyloidosis is treated by a team of specialists. The University has been involved in investigating new medications for cardiac TTR amyloidosis, one of which (tafamidis) is now FDA approved.

Key services include:

• R Adams Cowley Shock Trauma Center
• UM Children’s Hospital
• UM Greenebaum Comprehensive Cancer Center
• Transplant
• Heart and Vascular
• Stroke
• Time-Sensitive Critical Care

The team includes healthcare professionals in the following areas:
Hematology and Oncology:


The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.